Latest filing published 03 Jun 2025 for bluebird bio, Inc.. Read the official filing
This profile gathers the share dealings of Richard A. Colvin in bluebird bio, Inc. The record holds 14 filings, for trades running from 1 November 2022 to 30 May 2025.
No open-market purchase appears, only 9 sales worth €26k. Besides market trades, the filings include 4 share grants. 2025 to date brings no purchases and 3 sales.
On 3 June 2025 came the latest disclosure, a transaction in bluebird bio, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations